Crystal structure of inhibitor-bound human MSPL that can activate high pathogenic avian influenza
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Infection of certain influenza viruses is triggered when its HA is cleaved by host cell proteases such as proprotein convertases and type II transmembrane serine proteases (TTSP). HA with a monobasic motif is cleaved by trypsin-like proteases, including TMPRSS2 and HAT, whereas the multibasic motif found in high pathogenicity avian influenza HA is cleaved by furin, PC5/6, or MSPL. MSPL belongs to the TMPRSS family and preferentially cleaves [R/K]-K-K-R↓ sequences. Here, we solved the crystal structure of the extracellular region of human MSPL in complex with an irreversible substrate-analog inhibitor. The structure revealed three domains clustered around the C-terminal α-helix of the SPD. The inhibitor structure and its putative model show that the P1-Arg inserts into the S1 pocket, whereas the P2-Lys and P4-Arg interacts with the Asp/Glu-rich 99-loop that is unique to MSPL. Based on the structure of MSPL, we also constructed a homology model of TMPRSS2, which is essential for the activation of the SARS-CoV-2 spike protein and infection. The model may provide the structural insight for the drug development for COVID-19.
Article activity feed
-
-
-
-
SciScore for 10.1101/2020.06.12.149229: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Complex formation, crystallization, and data collection: The peptide inhibitor (decanoyl-RVKR-cmk) was purchased from Merck-Millipore and reconstituted in dimethyl sulfoxide (DMSO). Merck-Milliporesuggested: NoneDiffraction data were processed using the program iMosflm (31), followed by Aimless (32). iMosflmsuggested: (iMosflm , RRID:SCR_014217)The model of SPD was manually fixed with COOT (34) and refined with Refmac5 (35). COOTsuggested: (Coot, RRID:SCR_014222)All the structures … SciScore for 10.1101/2020.06.12.149229: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Complex formation, crystallization, and data collection: The peptide inhibitor (decanoyl-RVKR-cmk) was purchased from Merck-Millipore and reconstituted in dimethyl sulfoxide (DMSO). Merck-Milliporesuggested: NoneDiffraction data were processed using the program iMosflm (31), followed by Aimless (32). iMosflmsuggested: (iMosflm , RRID:SCR_014217)The model of SPD was manually fixed with COOT (34) and refined with Refmac5 (35). COOTsuggested: (Coot, RRID:SCR_014222)All the structures in the figures were prepared using PyMOL (http://www.pymol.org/). PyMOLsuggested: (PyMOL, RRID:SCR_000305)Homology modelling of TMPRSS2: The sequence alignment of the extracellular region of MSPL and TMPRSS2 was obtained using the BLAST webserver (https://www.uniprot.org/blast/). BLASTsuggested: (BLASTX, RRID:SCR_001653)The homology model of TMPRSS2 was build using MODELLER (37). MODELLERsuggested: (MODELLER, RRID:SCR_008395)Results from OddPub: Thank you for sharing your data.
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on pages 25 and 22. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-